Comments
Aetna expands coverage of Dendreon drug; stock jumps
29.09.2012. | (Reuters) - Health insurer Aetna Inc said on Friday it will pay for a greater number of patients to receive Provenge, the prostate cancer drug made by Dendreon Corp, sending Dendreon's shares up as much as 10 percent....
